JAAD psychodermatology paper covers U.S. court cases from 1914–2025

By Tom Whitfield

A paper spanning U.S. psychodermatology court cases from 1914 through 2025 carries a November 2026 publication date. The supplied citation places it in the Journal of the American Academy of Dermatology, Volume 95, Issue 5.

The title, “Medico-legal characteristics of psychodermatology cases in US courts (1914-2025),” defines a legal rather than clinical frame. The citation names no patient cohort, trial design, comparator, treatment, follow-up period, or clinical endpoint.

What does the November 2026 paper cover?

The stated scope concerns U.S. court cases involving psychodermatology from 1914 through 2025. That period describes the legal material named in the title, not a clinical observation window.

The citation does not say whether the authors examined every eligible case or selected a sample. It gives no number of cases, courts, judicial opinions, settlements, trials, or appeals.

No federal-versus-state distribution appears in the record. Nor does it identify a case mix involving district courts, appellate courts, state courts, or any other forum.

Those omissions prevent a reliable count of decisions or a trend across the stated span. The date range is exact; the paper’s denominator is not stated.

What does the citation establish?

The journal, publication month, volume, issue, title, authors, and 1914–2025 period are verifiable from the record. Those data establish the publication venue and date, not the paper’s findings.

The supplied text contains no abstract. It reports no diagnostic distribution, legal theory, holding, damages award, liability finding, or frequency analysis.

No clinical outcome measure or safety estimate appears either. Accordingly, the citation cannot support conclusions about treatment efficacy, disease severity, causation in an individual case, or recurrence.

Who wrote the paper?

Isha Gandhi is the first of 10 listed authors. Ruizhi Zhang, Rashika Shetty, Lana Kamel, Jeremy Haviv, Lealani Kidd, Deena Fayyad, Nathan Keller, Chase Fishman, and Jenna Dick complete the byline.

The record provides no affiliations, author roles, interview, or direct quotation. No statement can be attributed to Gandhi or her nine colleagues beyond their listed participation in the paper.

An author list identifies contributors, but it does not establish specialty, institutional perspective, or agreement with every conclusion. Readers must wait for the article itself to assess methods, disciplinary balance, and interpretive limits.

What would make the paper clinically useful?

A full article would need to define which cases counted as psychodermatology. It would also need a case count, court selection, years analyzed, diagnostic criteria, and legal outcomes.

Those details would let clinicians distinguish recurring issues from isolated disputes. They would also show whether dermatologic evidence appeared consistently throughout the 1914–2025 period.

The citation supports no such pattern. It does not identify the legal issues, evidence types, legal theories, or procedural outcomes analyzed.

Without those details, clinicians cannot judge which rules of decision, evidentiary standards, or outcomes the paper synthesized. Any comparison among courts, periods, or diagnostic groups also remains unreported.

What can readers say now?

The defensible takeaway is narrow: a 10-author medico-legal psychodermatology paper is dated for November 2026 in JAAD, Volume 95, Issue 5. Its stated U.S. court-case period begins in 1914 and ends in 2025.

The citation does not disclose whether the work is systematic, narrative, retrospective, or based on a selected case series. It supplies no effect size, confidence interval, case count, or outcome tally.

Accordingly, no conclusion about legal success, diagnostic accuracy, causation, liability, or damages appears justified from this record. That limitation applies even though the title promises “medico-legal characteristics”; the characteristics remain unspecified here.

Any stronger account would go beyond the source. The next useful update is the article’s methods and results, especially its case denominator, court distribution, diagnostic criteria, and legal outcomes.